Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose heparinization in elective OPCAB surgery
2016-001529-15Phase 4Terminated
- Sponsor
- ASST Lecco
- Start
- Sep 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of heparin in coronary arteriosclerosis (2 arms), sponsored by ASST Lecco. Primary endpoints: Composite vascular endpoint and Composite perioperative major bleeding endpoint. Started Sep 2021; status: terminated.
02
Drugs
heparin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2016-001529-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001529-15.